Lyophilised vial

BPC-157 Thymosin Beta-4 Capsules

CapsulesIdentity confirmed (MS)

£180.15

BPC-157 Thymosin Beta-4 Capsules combine BPC-157, a 15-amino-acid pentadecapeptide, with Thymosin Beta-4, a 43-amino-acid peptide, in capsule form for laboratory research.

Card payments acceptedVISAalso bank transfer, Zelle and crypto
  • Sealed under inert gas, dispatched same day by tracked courier.
  • Independently tested by an ISO-accredited laboratory.
  • Damaged or off-spec on arrival, replaced or refunded within 14 days.

About this compound

Work reported in the experimental literature bears on the two peptides held in these capsules: BPC-157, a pentadecapeptide of 15 amino acids, and Thymosin Beta-4, a 43-amino-acid peptide. For BPC-157 the published areas take in angiogenesis, vascular biology, extracellular matrix biology, cellular migration, connective tissue biology, gastrointestinal biology, inflammatory signalling, neurobiology and musculoskeletal models.

Thymosin Beta-4 has likewise drawn scientific attention within peptide biology and cellular processes. Each compound is studied in experimental models, and the published record keeps their respective research areas apart.

Compound breakdown

Molecular weightCAS numberFormulaPurity (HPLC)FormatCurrent batch
Purity and identity are third-party measured. Sourcing, synthesis and handling statements are manufacturer-supplied and labelled as such.
Certificate of analysis
● Verified

No certificate has been published for this compound yet — the batch code and lab report will appear here once testing is complete.

Published before you buy — this certificate is matched to the batch you receive, not to the sale.